A Phase 2, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of V117957 in Subjects With an Alcohol Use Disorder Who Are Experiencing Insomnia Associated With Alcohol Cessation
Phase: PHASE2
Conditions: Insomnia
Sponsor: Imbrium Therapeutics

Official Title:  A Phase 2, Randomized, Double-Blind, Multi-Center, Placebo-
Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of 
V117957 in Subjects with an Alcohol Use Disorder who are Experiencing Insomnia 
Associated with Alcohol Cessation
NCT #: NCT04035200
Date of Document: September 27, 2019